Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, February 19, 2026
Lonza announced that it has strengthened its Advanced Synthesis offering to increase phase-appropriate support for the discovery and development of antibody-drug conjugates (ADCs) and other bioconjugates.
read more
Wednesday, February 18, 2026
Rezon Bio announced that its Warsaw-Duchnice facility has received approval from the FDA for the commercial manufacturing of a biosimilar.
read more
Wednesday, February 18, 2026
OFD Life Sciences, a division of Oregon Freeze Dry, announced that Danielle Grosso has joined the organization as the Senior Director of Project Management.
read more
Tuesday, February 17, 2026
Uniphar announced a strategic merger between Uniphar | Clinical and BMclinical, reinforcing Uniphar | Clinical’s integrated clinical supply offering and solidifying its position as a trusted partner to pharmaceutical and biotech companies worldwide.
read more
Tuesday, February 17, 2026
DFE Pharma has introduced a continuous manufacturing (CM) platform designed to support formulation development, process optimization, and lifecycle management for pharmaceutical products.
read more
Tuesday, February 17, 2026
CS Analytical has expanded its pharmaceutical testing services with the launch of Raw Material Analytical, adding raw material and finished product testing capabilities for pharmaceutical, biopharmaceutical, and related industries.
read more
Tuesday, February 17, 2026
Capricorn Scientific has expanded its European operations with a new 4,000m² logistics and infrastructure hub in Ebsdorfergrund, Germany.
read more
Wednesday, February 11, 2026
Kincell Bio announced a new collaboration with RegCell. Under the partnership, Kincell Bio will provide comprehensive CMC development and GMP manufacturing support to accelerate RegCell’s lead Treg program toward clinical trial evaluation.
read more
Wednesday, February 11, 2026
Syngene International announced a strategic collaboration with Johns Hopkins University, MD, U.S., to advance early stage drug discovery programs and platform technologies emerging from the university’s research labs.
read more
Wednesday, February 11, 2026
Rentschler Biopharma SE announced the appointment of Veit Bergendahl, PhD, as Chief Operating Officer (COO) and member of the Executive Board. He succeeds Christiane Bardroff, who has decided to pursue a new professional opportunity outside the ...
read more
Wednesday, February 11, 2026
IQVIA and the Duke Clinical Research Institute (DCRI) announced a collaboration to enhance the conduct of clinical research in obesity and related cardiometabolic trials.
read more
Tuesday, February 10, 2026
MMS, a global, data-focused clinical research organization (CRO), announced that Somya Dunn, MD, has joined the company as Senior Medical Director, Safety Risk Management, further advancing the company’s leadership in risk-benefit assessments for ...
read more
Tuesday, February 10, 2026
Azenta announced a strategic partnership with Frontier Space to conduct cutting-edge scientific experiments in space. This collaboration aims to harness the unique benefits of the microgravity environment to accelerate discovery and innovation in ...
read more
Tuesday, February 10, 2026
Experic, a CDMO and clinical trial supply services company serving the biopharmaceutical industry, announced the appointment of Matthew Mollan, Ph.D., as Chief Executive Officer.
read more
Tuesday, February 10, 2026
AsymBio, a subsidiary of Asymchem Group , announced that it has established integrated technology platforms spanning the full biopharmaceutical development lifecycle. Through its end-to-end service capabilities, the company provides streamlined, ...
read more